Model-integrated strategies for bioequivalence evaluation of drugs with high variability and/or long half-life
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40122C00139
- Awardee
-
Uppsala Universitet UEI KTRDK57SR316
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $527,318
Award facts
- Opportunity
-
- FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Solicitation · FDABAA2200123 · Posted Nov 10, 2021
- Contract value 100% obligated
- $527,318.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 165 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Sweden
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $261,950 | |
| Original award | $265,368 |
About this award
The Food and Drug Administration awarded a $527,318 cost-no-fee definitive contract to Uppsala Universitet on September 26, 2022, for model-integrated strategies for bioequivalence evaluation of drugs with high variability and long half-life. No set-aside was used. A no-cost modification moved the ultimate completion date to March 31, 2025. The award place of performance is Sweden.
The originating Broad Agency Announcement, posted November 10, 2021, with proposals due January 21, 2022, sought regulatory science research and development proposals across nine areas to develop tools, standards, and approaches for evaluating the safety, efficacy, and quality of FDA-regulated products. It was open to private, academic, and government entities, carried no set-aside, and remains open until further notice. The BAA states that research and development activities take place in Silver Spring, Maryland.
Service Contract Inventory rows report 1.1 FTEs and 2,200 contractor hours in FY2023, and 3.7 FTEs and 7,597 contractor hours in FY2024. FY2025 shows $527 thousand invoiced and 0.2 FTEs. The derived government-paid hourly rate is $0.00/hr for both FY2023 and FY2024, and the reported trend across years is mixed. The prime self-performed all reported FY2025 hours, with no subcontractors reported.
Quick answers
Who was awarded contract 75F40122C00139?
75F40122C00139 was awarded to Uppsala Universitet by Food and Drug Administration (Department of Health and Human Services) on September 26, 2022.
How much is contract 75F40122C00139 worth?
The government has obligated $527,318 on 75F40122C00139.
Was contract 75F40122C00139 competed?
The extent of competition for 75F40122C00139 was full and open competition. The government received 165 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award